Summary:
- Researchers have identified that the anti-epileptic medication lamotrigine shows potential in reducing the frequency and intensity of migraine auras in patients.
- The study suggests that by stabilizing neuronal membranes and modulating glutamate release, the drug may help mitigate the cortical spreading depression associated with the visual and sensory disturbances of auras.